Advanced Search

Show simple item record

Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment

dc.contributor.authorCinpolat, Havva Yasemin
dc.contributor.authorAlkan, Sevil
dc.contributor.authorAltınışık, Hatice Betül
dc.contributor.authorÜlker Çakır, Dilek
dc.contributor.authorOğuzman, Hamdi
dc.date.accessioned2024-01-23T05:31:23Z
dc.date.available2024-01-23T05:31:23Z
dc.date.issued2023en_US
dc.identifier.citationÇinpolat, H.Y., Alkan, S., Altınışık, H.B., Ülker Çakır, D., & Oğuzman, H. (2023). Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment. Labmedicine. https://doi.org/10.1093/labmed/lmad009 ‌en_US
dc.identifier.issn0007-5027 / 1943-7730
dc.identifier.urihttps://doi.org/10.1093/labmed/lmad009
dc.identifier.urihttps://hdl.handle.net/20.500.12428/5310
dc.description.abstractObjective In this study, we aimed to evaluate the serum creatinine (SCr) levels with the reference change value (RCV) in patients receiving colistin treatment. Methods We retrospectively recorded the SCr levels of 47 patients receiving colistin treatment before treatment and on days 3 and 7 after treatment. RCV was calculated with the asymmetrical RCV formula (Z = 1.64, P < .05). Percent (%) increase in the SCr results of the patients was compared with RCV and values exceeding RCV were regarded as statistically significant. Results The RCV was calculated as 15.6% for SCr. Compared with pretreatment values, SCr value on day 3 was 32/47 and on day 7 it was 36/47; as these results exceeded RCV, they were considered statistically significant. Conclusion Use of RCV in the interpretation of results between serial measurements will provide a more rapid and sensitive method when making decisions.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectBiological variationen_US
dc.subjectColistinen_US
dc.subjectAdverse effectsen_US
dc.subjectToxicityen_US
dc.subjectClinical chemistryen_US
dc.subjectReference valuesen_US
dc.titleEvaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatmenten_US
dc.typearticleen_US
dc.authorid0000-0002-7161-2907en_US
dc.authorid0000-0003-1944-2477en_US
dc.authorid0000-0001-9273-0876en_US
dc.authorid0000-0002-8796-6363en_US
dc.relation.ispartofLaboratory Medicineen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.institutionauthorCinpolat, Havva Yasemin
dc.institutionauthorAlkan, Sevil
dc.institutionauthorAltınışık, Hatice Betül
dc.institutionauthorÜlker Çakır, Dilek
dc.identifier.doi10.1093/labmed/lmad009en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorwosidAAF-7323-2019en_US
dc.authorwosidABH-8663-2020en_US
dc.authorwosidAAB-3412-2022en_US
dc.authorwosid-en_US
dc.authorscopusid56717756300en_US
dc.authorscopusid57526218800en_US
dc.authorscopusid56678636800en_US
dc.authorscopusid8595648600en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.wosWOS:000945370100001en_US
dc.identifier.pmidPMID: 36883236en_US


Files in this item

Name:
Havva_Yasemin_Cinpolat_Makale.pdf
Size:
212.0Kb
Format:
PDF
Description:
Araştırma Makalesi
View/Open
Name:
license_rdf
Size:
913bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess